We are excited to welcome you to the first edition of “King’s Clinical Updates on Diabetes, Endocrinology & Obesity” which will be held on Friday, 17 June 2022 at Address Dubai Mall, Dubai, UAE. The team at King’s worked hard to put together a stimulating and innovative program with quality education and scientific content which is also highly clinically relevant.
The conference will host key note lectures, plenary symposia, group discussions and a technical exhibition – the combination of all these elements provides delegates, partners and all other stakeholders with their own unique experience.
This unique event provided thought provoking lectures with cutting edge information alongside detailed discussions on various topics on Diabetes and Endocrinology.
Our delegates would be from a multi-disciplinary background, giving you a unique opportunity to engage and network with professionals from General Medicine, Family Medicine, Endocrinology etc.
The Conference has been organized to promote a wide range of topics and attracts an excellent faculty of local and international speakers who are experts and industry leaders in their fields.
About King’s Institute of Diabetes, Endocrinology and Obesity (KIDEO) – Opening Soon
KIDEO is the future King’s Center of Excellence to manage cases with variety of metabolic conditions ranging from diabetes to its complications and all endocrine conditions including weight management services for morbid obesity. There will be a multidisciplinary team approach to provide state-of-the-art diagnostic as well as therapeutic services in these areas of speciality. This will be of 1 stop shop for patients with chronic conditions like diabetic neuropathy, diabetic retinopathy, diabetic nephropathy, diabetic foot problems, gestational diabetes, thyroid hormonal imbalance, pituitary problems, non-alcoholic fatty liver disease, adrenal problems, erectile dysfunction, perimenopausal or menstrual problems, testosterone deficiency problems, polycystic ovarian syndrome, dyslipidemia, cardio metabolic risks associated with metabolic syndrome and diabesity.
Patient’s we will receive the highest standards of care as advised by reputed guidelines and recommendations from across the Globe. Standards of care would be met to reach the same goals as advised by joint British diabetes society guidelines, British thyroid associations guidelines, endocrine society guidelines, American diabetes associations guidelines, American thyroid associations guidelines, nice guidelines and DHA guidelines.
Patient’s with the above problems require long-term chronic follow-ups with regular monitoring which would be provided through this center of excellence. This will be the only one stop shop for such chronic conditions across the region.